ABCB5+ mesenchymal stem cell transplantation in a chronic liver disease mouse model
V Hartwig(Heidelberg University), Steven Dooley(Heidelberg University), Anne Dropmann(University Hospital Heidelberg), Bedair Dewidar(Tanta University), NM Meindl-Beinker(Heidelberg University), Andreas Kluth(Rheacell (Germany)), Christoph Meyer(Heidelberg University), Nils Tappenbeck(Rheacell (Germany))
Cited by 0
Related Papers
<scp>TGF</scp>‐β signalling and liver disease
|FEBS Journal|2016|611
μ1A-adaptin-deficient mice: lethality, loss of AP-1 binding and rerouting of mannose 6-phosphate receptors
|The EMBO Journal|2000|409
Hepatocyte-Specific Smad7 Expression Attenuates TGF-β–Mediated Fibrogenesis and Protects Against Liver Damage
|Gastroenterology|2008|272
Metabolic liver disease in diabetes – From mechanisms to clinical trials
|Metabolism|2020|156